24 CHILDREN aged 6/23 months and 36 CHILDREN aged 24/48 months: AUTHORIZED FOURTH DOSE with bivalent
… 6 months through 4 years of age who completed their three-dose primary series with the monovalent Pfizer-BioNTech
… are now eligible to receive a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent
… FDA evaluated immune response data from 60 children in this age group
… safety was assessed in participants in two clinical studies
… 24 participants 6 months through 23 months
… 36 participants 2 years through 4 years of age
